Inspiring Science, Advancing Care

To improve access to non-invasive radiation therapy and expand treatment applications
Xstrahl delivers medical and research systems to improve access to non-invasive radiation therapy and expand treatment applications.


We connect experts to advance radiation therapy and research


We know radiation and how to support it from the lab to the clinic


We support new possibilities in X-ray technology and its application


Treat BCC and SCC with Low-Energy Radiation Therapy

Skin cancer is on the rise worldwide. Both radiation oncologists and dermatologists can deliver office-based electronic brachytherapy (EBT therapy), superficial radiation therapy, and orthovoltage therapies for cancer treatment with treatment outcomes similar to surgery.


Expand Non-Invasive Techniques to Treat Benign Disease

Radiotherapy can be efficacious in the treatment of a variety of benign conditions, such as keloid scarring, Dupuytren’s contracture, and Ledderhose disease, providing maximum comfort to the patient without surgical risks. Patient selection criteria is important.


Support Patients with Maximum Comfort

Soft tissue metastases and secondary lesions often respond favorably to low doses of radiation, giving patients a better quality of life with minimal treatment time. X-ray therapy providers are able to design treatments that are tailored specifically to the patient’s cancer.


Open Doors to Translational Radiation Research

Perform clinically relevant radiation experiments that yield translational data using targeted radiation. Life science investigators, radiation oncologists, radiation physicists, and many other disciplines can carry out a variety of research initiatives with Xstrahl radiation research equipment.


We can explain more about our clinical radiation and research systems anytime


Xstrahl 100

I am so pleased that I chose SRT over reconstructive surgery. The treatment was very manageable. There was no “down time”. I continued my normal, daily schedule. The SRT was most successful as there is no evidence of treatment or basal cell on my nose now. I am so grateful SRT was an option.

– Patient, The Skin Cancer and Reconstructive Surgery Center (SCARS Center), California, USA

Xstrahl 150

Here at Valley View, we have been using the Xstrahl 150 model to treat a high proportion of our patients with skin cancers and keloids for over 3 years now. When we were deciding which superficial radiotherapy unit to purchase, we were attracted to the Xstrahl models because they offered higher energies compared to competitor units. We also liked detailed features of the machine such as the water-cooling system and the interlock option on the filter selection. We love using the Xstrahl radiotheraphy system to treat our patients because of its user-friendly technology and variety of energy levels available. The system is very reliable and we have had 100% up time.

– Medical Physicist, Valley View Hospital, Glenwood Springs, USA

Xstrahl 200

The addition of an Xstrahl X-ray therapy system for treating superficial skin conditions such as non-melanoma skin cancer, will not only allow us to offer treatment to patient more effeciently, but also provide an enhanced patient experience. We are constantly striving to meet patient demand which is ever increasing and we are excited to have this option available to our patients.

– Principle Radiographer, Colney Center, Norfolk & Norwich University Hospitals, Great Britain

Xstrahl 300

Xstrahl radiotherapy systems help us to respond to a growing treatment demand, helping us to reduce surgical and hospitalisation costs. The team find the Xstrahl technology easy to use and helps them to deliver safe and effective radiotherapy to our patients.

– MD, Photoradiotherapy Department, Dermatology Unit, Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, Milan, Italy

Featured News

Xstrahl to Highlight Superficial and Orthovoltage Radiotherapy Solutions for Skin Cancer and Selective Benign Conditions at AAPM 2024

Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions at the 66th Annual Meeting & Exhibition of the American Association of Physicists in Medicine (AAPM) in Los Angeles, CA, from July 21-25, 2024, at booth 518.

Dose-dependent changes in cardiac function, strain and remodelling in a pre-clinical model of heart base irradiation

Xstrahl in Action Advances in conformal radiotherapy (RT) techniques and image-guidance have significantly reduced organs at risk (OAR) exposure, which has been associated with improved safety profiles. However, opportunities remain to further optimise treatments...


Research & Education


Learn more about Xstrahl products in action.

Dermatologist examines patient


See what’s new in clinical practice and research

Recent Presentations

Watch clinicians, researchers, and Xstrahl staff highlight important education topics


Recent Case Studies

Learn more about patients who have been treated using Xstrahl equipment


Recent Publications

View journal abstracts and articles that feature Xstrahl clinical and research systems


Contact Us

Find out more about how Xstrahl will work tirelessly for you